Back Matter (PDF) - Clinical Chemistry
Back Matter (PDF) - Clinical Chemistry
Back Matter (PDF) - Clinical Chemistry
Create successful ePaper yourself
Turn your PDF publications into a flip-book with our unique Google optimized e-Paper software.
Estrone<br />
mess. of estrone-3-ghucuronide in urine by<br />
rapid, homogeneous time-resolved<br />
fluoroimmunoasssy, 555<br />
sohid-phase enzymoimmunoassay of estrone in<br />
saliva, 569<br />
Ethanol<br />
See also Alcohol<br />
confirmatory breath ethanol tasting (A), 1184<br />
EMIT’ ethanol assays for use on Cobas Mira<br />
and Cobas Bio analyzers (A), 1166<br />
evaln. of Abbott AD,” analyzer in traditional<br />
and nontraditional markets (A), 1174<br />
ET-18-OCH3<br />
detn. of the allyl lysophosphohipid derivative<br />
ET-18-OCH3, a new antineophastic drug, in<br />
phasma, 821<br />
Exercise, effects of<br />
alteration of lymphocyte subsets and endocrine<br />
response during 80 days of competitive swim<br />
training (A), 1136<br />
effect of exercise training on glycemic control,<br />
kidney function, and renal ultrastructure in<br />
obese (diabetic) Zucker rats (A), 1135<br />
effects of in vivo and in vitro production of<br />
hectic acid on ionized, protein-bound, and<br />
complex-bound Cain blood, 935<br />
heterogeneity of serum creatine<br />
isoenzyme MM in myocardial<br />
kinase<br />
infarction:<br />
chin, significance and post-synthetic<br />
conversion of “abnormal” sub-bands, 206<br />
lactate dehydrogenase in serum of patients<br />
performing an exercise test (L), 2016<br />
patterns of lactate dehydrogenase isoenzymes<br />
and 2 in serum on exercise (SN), 301<br />
I<br />
pyruvata mess, in whole blood with the Cobas<br />
Bio analyzer (TB), 325<br />
test-strip method for lactate in whole blood<br />
(SN), 1992<br />
Expert systems<br />
appln. of expert systems in the din, lab. (R),<br />
1595<br />
Exponential amplification<br />
quant. essays based on use of replicetable<br />
hybridization probes (S). 1826<br />
Extraceiluhar water<br />
antipyrine interferes with chem. detn. of Br in<br />
simultaneous estn, of total body H20 and<br />
extracellular H2O, 1367<br />
Factor III<br />
measuring tissue factor (Factor III) acty. in<br />
plasma, 1897<br />
Familial aniyloidotic polyneuropathy<br />
simplified screening of populations at risk far<br />
transthyretin Met30-asaocd. familial<br />
amyloidotic pohyneuropethy (SN), 1033<br />
Familial dy.albuniinemic hyperthyroxinemia<br />
evaln. of Amerliten VF4 method in patients<br />
with FDH and nonthyroidal illness (A), 1142<br />
Fanconi syndrome<br />
ehectrophoretic examin. of protainuria in<br />
Lowe’s syndrome and other causes of renal<br />
tubular Fanconi syndrome (SN), 2231<br />
Fatty acids<br />
See also Lipids, Triglycerides<br />
automated micromethod for measuring free<br />
fatty acids in plasma/serum (SN), 2228<br />
chemiluminescent detn. of nonesterified fatty<br />
acids in serum (TB), 325<br />
direct and indirect techniques for free thyroz.in<br />
compared in nonthyroidal illness I. effect of<br />
free fatty acids, 102<br />
do nonesterified fatty acids displace thyroxin<br />
from its plasma binding sites in severe<br />
nonthyroidal illnesses? (A), 931<br />
effect of thyroid hormone-binding proteins and<br />
fatty acids on modified analog assays of F’1’4<br />
and FF3 in serum (L), 708<br />
hang-chain aliphatic fatty acids and phytanic<br />
acid simultaneously measured by dualcolumn<br />
capillary chromatog. (SN), 1989<br />
low-normal concns. of free thyroxin in serum in<br />
hate pregnancy- physial. fact, not tech.<br />
artefact, 1891<br />
phytanic acid, pristanic acid, and very-langchain<br />
fatty acid methyl esters mess.<br />
simultaneously by capillary gas chromatog.<br />
(L),703<br />
prepn. of fecal samples for assay of volatile<br />
fatty acids by gas-hiq. chromatog. and<br />
HPLC, 74<br />
Feces<br />
chin, effective screening of asymptomatic<br />
patients for fecal occult blood loss requires<br />
lab, assistance (L), 2337<br />
comparison of sample preparation techniques<br />
for measurement of total N in stool and food<br />
samples by chemihuminescence (A), 1114<br />
effect of ingestion of hemoprotains on fecal<br />
excretion of hemes and porphyrins, 2290<br />
fecal chymotrypsin: suitable test for diagnosing<br />
pancreatic insufficiency (A), 1090<br />
“Fecatwin Sensitive” test for fecal occult blood<br />
not intended for use without testing positives<br />
with the FECA-ELA assay (L), 1555<br />
prepn, of fecal samples for assay of volatile<br />
fatty acids by gas-hiq. chromatog. and<br />
HPLC, 74<br />
thin-layer chromatog. of free porphyrins for<br />
diagnosis of porphyria (SN), 5043<br />
Ferrioxamine<br />
indirect mess, of desferrioxamine and its<br />
chelated cmps. aluminoxamine and<br />
ferrioxamine by Zeeman at. absorp.<br />
spectrom. (SN), 884<br />
Ferritin<br />
commercially available dissociation-enhanced<br />
hanthanide t’luoroimmunoassay kit evald. for<br />
quantifying ferritin in serum (TB), 327<br />
concns, of Se, Zn, Cu, Fe, Mg, K in blood and<br />
heart tissue in coronary heart disease (SN),<br />
851<br />
erythrocyte ferritin assay to find patients with<br />
homozygous hemochromatosis (A), 1083<br />
evaln. of ferritin on Abbott LMx’ automated<br />
immunoassay systems (A), 1099<br />
high serum ferritin level and its significance in<br />
cancer (A), 1081<br />
rapid det. of ferritin in serum by the<br />
“Stratus” fluoroenzymoinimunometric assay<br />
(TB), 672<br />
short- and lang-term variability of indices<br />
related to nutritional status. I: Ca, Cu, Fe,<br />
Mg, and Zn, 369<br />
solid-phase enzyme immunoassay of serum<br />
ferritin (A), 1203<br />
solid-phase immunofluorometric assay for<br />
human serum ferritin (A), 1189<br />
Fertility<br />
high concns. of Zna2-glycoprotein and lack of<br />
a2HS-ghycoprotein in ejaculates, 1649<br />
RIA of $-microseminopratein, a prostaticsecreted<br />
protein in sara of men and women,<br />
1497<br />
Fertility studies<br />
See also Infertility<br />
embryo cryopreservation (A), 1064<br />
hormonal evaln. of female infertility,<br />
reproductive disorders (CC), 620<br />
IVF-GIFT: enhanced reproductive technol.<br />
(A), 1063<br />
meas. of estrone-3-ghucuronide in urine by<br />
rapid, homogeneous time-resolved<br />
fluoroimmunoassay, 555<br />
ovarian stimulation monitoring (A), 1063<br />
solid-phase enzymoimmunoassay of estrone in<br />
saliva, 669<br />
Fetal status<br />
See also Amniotic fluid,<br />
Lecithin/sphingomyein ratio, etc.<br />
amniotic fluid lameilar bodies characterized by<br />
resistive-pulse counting: relation to measures<br />
of fetal lung maturity, 612<br />
automated rapid assessment of surfactant and<br />
fetal lung maturity by altered fluorescence<br />
polarization of a dye (PC16) (A), 1107<br />
comparison of tests used to assess fetal<br />
maturity (A), 1069<br />
lab. role in predicting fetal lung maturity (A),<br />
1241<br />
maternal serum estriol in screening for Down’s<br />
syndrome: significance of high SD for the<br />
population (A), 1193<br />
multicenter evaln. of TDx’ fetal hung maturity<br />
(A), 1075<br />
multicenter eveln. of TDx teat for assessing<br />
fetal lung maturity, 1005 - -<br />
phosphohipid surface tension: diagnostic utility<br />
of amniotic fluid and its lipid extract, an<br />
anal. of the value of pptn. with cold acetone,<br />
800<br />
Fetoprotein<br />
AFP quantn. compared using a semiautomated<br />
monoclonal and a -<br />
polyclonal-monoclonal immunoenzymatic<br />
assay (A), 1200<br />
alpha-fetoprotein assay and abnormal values<br />
(A), 1157<br />
biiary all, phosphatase measured by minicolumn<br />
chromatog. on DEAR-cellulose:<br />
appln. to detection of hepatobihiary diseases,<br />
1684<br />
chemiluminescent enzyme immunoassay of a-<br />
fetoprotein with adamantyl dioxetane<br />
phenyh phosphate as substrate (SN), 2319<br />
circulating antibodies to mouse monochonal<br />
immunoglobulins caused false-positive<br />
results in two-site assay for alphafetoprotein<br />
(L), 2339<br />
dissocn. of immunocomplexes by ionic shock<br />
for development of immunosensors: appln. to<br />
meas. of ai-fetoprotain (SN), 1026<br />
eveln. of Abbott IMx immunoassay analyzer<br />
for maternal serum alpha-fetoprotein<br />
screening of open neural tube defect and<br />
Down syndrome (A), 1195<br />
IMx” AFP, automated micropartiche<br />
immunoassay for AFP: performance<br />
characteristics and chin, studies (A), 1192<br />
performance characteristics and din, evaln. of<br />
the Abbott IMx AFP (A), 1092<br />
prospective study of Abbott AFP-EIA as an aid<br />
in detection of fetal neural tube defect (A),<br />
1192<br />
racial and other differences of maternal serum<br />
a-fetoprotein in a large obstetrical<br />
population (A), 1136<br />
variables involved in evaluating maternal<br />
serum alpha-fetoprotein: albumin, total<br />
protein and fructosamine (A), 1159<br />
Fiber Optic sensors<br />
intravascular monitoring techniques, risks and<br />
problems (A), 1059<br />
Fibrin<br />
monitoring hysis of fully cross-linked fibrin<br />
clots with comm. D-dimer teat (A), 1161<br />
Fibrinogen<br />
optimized microturbidimetric assay for<br />
fibrinogen.<br />
Fibronectin<br />
211<br />
See also Prealbumin<br />
fibronectin is unsuitable as a tumor marker in<br />
pleural effusiona (SN), 166<br />
Flame photometry<br />
enzymatic detn. of K in serum, 817<br />
Flecainide<br />
fhecainide: comparison of fluorescence<br />
polarization with HPLC (A), 1097<br />
Flow-injection analysis<br />
automated fluoroimmunoassay of theophyiline<br />
and vaiproic acid by flaw-injection anal. with<br />
use of HPLC (SN), 469<br />
Fluorescein<br />
interference by intravenous fluorescein with<br />
lab. tests (A), 1159<br />
Fluorescence immunoassay<br />
See Fhuoroimmunoassay, Immunoassay<br />
Fluorescence polarization<br />
automated rapid assessment of surfactant and<br />
fetal lung maturity by altered fluorescence<br />
polarization of a dye (PC 16) (A), 1107<br />
comparison of free digoxin and total dioxin:<br />
extent of interference from digoxin-hike<br />
immunoreactive substances in a fluorescence<br />
polarn. assay (TB), 323<br />
cost-effective assays for use in monitoring<br />
carbamazepine, phenobarbital, and<br />
phenytoin in serum (SN), 1782<br />
flecainide: comparison of fluorescence<br />
polarization with HPLC (A), 1097<br />
multicenter evaln. of TDx fetal lung maturity<br />
(A), 1075<br />
multicenter evaln. of TDx test for assessing<br />
fetal hung maturity, 1005<br />
TDM assays by fluorescence polarization on<br />
Cobas Fara IITNanalyzer; detn. of serum<br />
amikacin, gentamicin, and tobramycin (A),<br />
1178<br />
TDM assays by fluorescence polarization on<br />
Cobas Fare IITN:detn, of serum N-<br />
acetyhprocainamide, theophylline, and<br />
phenytoin (A), 1178<br />
Fluorescence polarization immunoassay<br />
AD” amphetamine class assay (A), 1174<br />
antiepieptic drug monitoring by FPIA and gas<br />
chromatography (A), 1208<br />
assay for benzodiazepines on the AD,’<br />
analyzer (A), 1174<br />
cm. performance of the EMIT vancomycin<br />
assay (SN), 1504<br />
comparison of Abbott TDx FPIA for<br />
cannabinoids with GC/MS (A), 1185<br />
cyclosporine concns. in blood after liver<br />
transplantn.: correlation of immunoassay<br />
results with chin. events, 564<br />
detection limit of the TDx fluorescence<br />
polarization immunoassay extended for<br />
benzoylecgonine in urine (SN), 2110<br />
development of TD./ADn fluorescence<br />
polarization immunoassay for detection of<br />
methadone in human urine (A), 1176<br />
digoxin-hike immunoreactivity in neonates and<br />
infants minimized by centrifugal<br />
ultrafiltration and FPIA (A), 1163<br />
2380 CLINICALCHEMISTRY, Vol. 35, No. 12, 1989